Manuscripts
Abstracts
June 3, 2022
Evaluating the impact of performance status criteria on minority eligibility for oncology clinical trials
ASCO Annual Meeting 2022
Bhandari S et al
June 3, 2022
Machine learning modeling of real-world primary resistance and hyperprogression in immune checkpoint inhibitor (ICI) treated advanced non-small cell lung cancer (aNSCLC) patients
ASCO Annual Meeting 2022
Das R et al
June 3, 2022
Disparities in timely treatment among lung cancer patients
ASCO Annual Meeting 2022
Chhabra J et al
June 3, 2022
Comparison of DNA sequencing, immunohistochemistry, and in-situ hybridization techniques to determine HER2 status in metastatic breast cancer patients
ASCO Annual Meeting 2022
Lal LS et al
September 24, 2021
Care at the end of life during the COVID-19 pandemic: A CancerLinQ Discovery (CLQD) Analysis
ASCO Quality Care Symposium 2021
Rocque G et al
September 24, 2021
Survival in the Real World: A National Analysis of Patients Treated for Early Stage Breast Cancer
ASCO Quality Care Symposium 2021
Franks J et al
September 24, 2021
Development of a breast cancer-specific prognostic tool using CancerLinQ Discovery
ASCO Quality Care Symposium 2021
Ray E et al
September 8, 2021
Natural History and Real-World Treatment Outcomes for NSCLC Patients with EGFR Exon 20 Insertion Mutation: An IASLC- ASCO CancerLinQ Study
World Conference on Lung Cancer 2021
Behera M et al
August 25, 2021
The Friends of Cancer Research Real World Data (RWD) Pilot 2.0 Collaboration: Implementation of Standardized Methodological Approaches for Evaluation of Oncology RWD
ICPE Annual Conference 2021
Rivera D et al
